Clinical Trial Update: Efficacy and Safety of Propranolol Versus Acebutolol on the Proliferative Phase of Infantile Hemangioma [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing propranolol to acebutolol for the proliferative phase of infantile hemangioma was terminated. No efficacy or safety data are provided …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infantile Hemangioma

Drugs mentioned

• Acebutolol (Acebutolol)
• Propranolol (propranolol)

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Hemangioma | Phase 3 | Status: TERMINATED